Study Provides Preliminary Evidence in Favor of a New Type 1 Diabetes Treatment
Researchers have discovered preliminary evidence for a new type 1 diabetes treatment using the drug DFMO, supplied by UF startup Panbela Therapeutics.
Enterade Partners With 7-Time Olympic Medalist and Cancer Survivor Shannon Miller
UF Innovate startup company Enterade has teamed up with 7-time Olympic medalist, gymnast, and cancer survivor Shannon Miller to promote their non-prescription medical drink as a key part of the chemotherapy healing and recovery process.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
UF researchers have discovered a combination of two over-the-counter compounds that may significantly improve the recovery of patients infected with COVID-19. Studies in mice have been successful, with the health of test subjects improving significantly or ending in full recovery.
First Case of Accelerated Healing of a Recalcitrant Diabetic Ulcer Using Purified Amniotic Fluid
Neobiosis LLC, a client of UF Innovate | Accelerate @Sid Martin Biotech, recently presented the first case of accelerated healing of a diabetic ulcer using purified amniotic fluid. This research poses the use of this fluid as a possible treatment method for diabetic foot ulcers, one of the most painful complications of diabetes, and a difficult one to treat.
Medical AI Tool From UF, Nvidia Gets Human Thumbs-Up in First Study
Researchers from the University of Florida and Nvidia have created an AI computer program that can generate accurate doctors’ notes, opening the door for AI to support health care workers with groundbreaking efficiencies.
Keep an Eye on Carinata
University of Florida researchers have teamed up with company Nuseed to research the viability of carinata, a crop that reduces carbon output and helps mitigate climate change.
etectRx and the Village at Gainesville Announce Intelligent Incontinence Care Collaboration
UF Innovate client etectRX recently announced a first-of-its-kind pilot project with The Village at Gainesville, a vibrant retirement community. The project will center around the company’s “eBrief” technology, a patented intelligent incontinence monitoring system.
Tech Tuesday – Tyler Loftus
On this Tech Tuesday segment, Melanie Morón interviews Tyler Loftus, a trauma surgeon in the UF Department of Surgery whose research focuses on improving patient care in ICU setting using AI.
Budding Brainiacs: New Fellowship Program at the McKnight Brain Institute Offers Mentorship From Leading Neuroscientists
The UF McKnight Brain Institute’s competitive new fellowship program, Gator NeuroScholars, aims to boost the University’s research capabilities to solve the worlds’s most complex diseases. The program provides post-docs from a wide variety of backgrounds with mentorship from some of the world’s leading neuroscientists, driving discovery and innovation across the University.
Atsena Therapeutics Receives FDA Designation for Treatment of Severe Congenital Eye Disease Using Gene Therapy
Atsena Therapeutics has been granted Regenerative Medicine Advanced Therapy designation from the FDA to continue their research on a cure to Leber congenital amaurosis. Patients with this disease are missing a gene that regulates retinal function and visually-guided behavior, causing blindness at an early age.